Report Detail
COVID-19 Impact on Global Immuno-Cell Therapy Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4121430 |
- 10 August, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Medical Industry
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
Market Analysis and Insights: Global Immuno-Cell Therapy Market
The research report studies the Immuno-Cell Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Immuno-Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Immuno-Cell Therapy Scope and Segment
The global Immuno-Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Passive Immune (NK, LAK etc)
Active Immune
by Application, this report covers the following segments
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Global Immuno-Cell Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Immuno-Cell Therapy key players in this market include:
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
1 Market Overview of Immuno-Cell Therapy
- 1.1 Immuno-Cell Therapy Market Overview
- 1.1.1 Immuno-Cell Therapy Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global Immuno-Cell Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
- 1.3 Global Immuno-Cell Therapy Market Size by Region (2015-2026)
- 1.4 Global Immuno-Cell Therapy Historic Market Size by Region (2015-2020)
- 1.5 Global Immuno-Cell Therapy Market Size Forecast by Region (2021-2026)
- 1.6 Key Regions, Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
- 1.6.1 North America Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
- 1.6.2 Europe Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
- 1.6.3 Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
- 1.6.4 Latin America Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
- 1.6.5 Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2015-2026)
2 Immuno-Cell Therapy Market Overview by Type
- 2.1 Global Immuno-Cell Therapy Market Size by Type: 2015 VS 2020 VS 2026
- 2.2 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
- 2.3 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)
- 2.4 Passive Immune (NK, LAK etc)
- 2.5 Active Immune
3 Immuno-Cell Therapy Market Overview by Application
- 3.1 Global Immuno-Cell Therapy Market Size by Application: 2015 VS 2020 VS 2026
- 3.2 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
- 3.3 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)
- 3.4 Oncology
- 3.5 Cardiovascular Disease (CVD)
- 3.6 Orthopedic
- 3.7 Wound Healing
- 3.8 Others
4 Global Immuno-Cell Therapy Competition Analysis by Players
- 4.1 Global Immuno-Cell Therapy Market Size (Million US$) by Players (2015-2020)
- 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Cell Therapy as of 2019)
- 4.3 Date of Key Manufacturers Enter into Immuno-Cell Therapy Market
- 4.4 Global Top Players Immuno-Cell Therapy Headquarters and Area Served
- 4.5 Key Players Immuno-Cell Therapy Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Immuno-Cell Therapy Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 MEDINET Co
- 5.1.1 MEDINET Co Profile
- 5.1.2 MEDINET Co Main Business
- 5.1.3 MEDINET Co Products, Services and Solutions
- 5.1.4 MEDINET Co Revenue (US$ Million) & (2015-2020)
- 5.1.5 MEDINET Co Recent Developments
- 5.2 Erytech
- 5.2.1 Erytech Profile
- 5.2.2 Erytech Main Business and Company’s Total Revenue
- 5.2.3 Erytech Products, Services and Solutions
- 5.2.4 Erytech Revenue (US$ Million) (2015-2020)
- 5.2.5 Erytech Recent Development and Reaction to Covid-19
- 5.3 Seta Clinic Group
- 5.5.1 Seta Clinic Group Profile
- 5.3.2 Seta Clinic Group Main Business
- 5.3.3 Seta Clinic Group Products, Services and Solutions
- 5.3.4 Seta Clinic Group Revenue (US$ Million) & (2015-2020)
- 5.3.5 Takeda Recent Developments
- 5.4 Takeda
- 5.4.1 Takeda Profile
- 5.4.2 Takeda Main Business
- 5.4.3 Takeda Products, Services and Solutions
- 5.4.4 Takeda Revenue (US$ Million) & (2015-2020)
- 5.4.5 Takeda Recent Developments
- 5.5 SBI Holdings
- 5.5.1 SBI Holdings Profile
- 5.5.2 SBI Holdings Main Business
- 5.5.3 SBI Holdings Products, Services and Solutions
- 5.5.4 SBI Holdings Revenue (US$ Million) & (2015-2020)
- 5.5.5 SBI Holdings Recent Developments
- 5.6 Oxford BioTherapeutics
- 5.6.1 Oxford BioTherapeutics Profile
- 5.6.2 Oxford BioTherapeutics Main Business
- 5.6.3 Oxford BioTherapeutics Products, Services and Solutions
- 5.6.4 Oxford BioTherapeutics Revenue (US$ Million) & (2015-2020)
- 5.6.5 Oxford BioTherapeutics Recent Developments
- 5.7 Fate Therapeutics
- 5.7.1 Fate Therapeutics Profile
- 5.7.2 Fate Therapeutics Main Business and Company’s Total Revenue
- 5.7.3 Fate Therapeutics Products, Services and Solutions
- 5.7.4 Fate Therapeutics Revenue (US$ Million) (2015-2020)
- 5.7.5 Fate Therapeutics Recent Development and Reaction to Covid-19
- 5.8 Gilead Sciences
- 5.8.1 Gilead Sciences Profile
- 5.8.2 Gilead Sciences Main Business
- 5.8.3 Gilead Sciences Products, Services and Solutions
- 5.8.4 Gilead Sciences Revenue (US$ Million) & (2015-2020)
- 5.8.5 Gilead Sciences Recent Developments
- 5.9 Novartis
- 5.9.1 Novartis Profile
- 5.9.2 Novartis Main Business
- 5.9.3 Novartis Products, Services and Solutions
- 5.9.4 Novartis Revenue (US$ Million) & (2015-2020)
- 5.9.5 Novartis Recent Developments
- 5.10 Osiris
- 5.10.1 Osiris Profile
- 5.10.2 Osiris Main Business
- 5.10.3 Osiris Products, Services and Solutions
- 5.10.4 Osiris Revenue (US$ Million) & (2015-2020)
- 5.10.5 Osiris Recent Developments
- 5.11 Vericel Corporation
- 5.11.1 Vericel Corporation Profile
- 5.11.2 Vericel Corporation Main Business
- 5.11.3 Vericel Corporation Products, Services and Solutions
- 5.11.4 Vericel Corporation Revenue (US$ Million) & (2015-2020)
- 5.11.5 Vericel Corporation Recent Developments
- 5.12 Fujifilm Cellular Dynamics
- 5.12.1 Fujifilm Cellular Dynamics Profile
- 5.12.2 Fujifilm Cellular Dynamics Main Business
- 5.12.3 Fujifilm Cellular Dynamics Products, Services and Solutions
- 5.12.4 Fujifilm Cellular Dynamics Revenue (US$ Million) & (2015-2020)
- 5.12.5 Fujifilm Cellular Dynamics Recent Developments
- 5.13 JCR Pharmaceuticals
- 5.13.1 JCR Pharmaceuticals Profile
- 5.13.2 JCR Pharmaceuticals Main Business
- 5.13.3 JCR Pharmaceuticals Products, Services and Solutions
- 5.13.4 JCR Pharmaceuticals Revenue (US$ Million) & (2015-2020)
- 5.13.5 JCR Pharmaceuticals Recent Developments
- 5.14 Beike Biotechnology
- 5.14.1 Beike Biotechnology Profile
- 5.14.2 Beike Biotechnology Main Business
- 5.14.3 Beike Biotechnology Products, Services and Solutions
- 5.14.4 Beike Biotechnology Revenue (US$ Million) & (2015-2020)
- 5.14.5 Beike Biotechnology Recent Developments
- 5.15 Golden Meditech
- 5.15.1 Golden Meditech Profile
- 5.15.2 Golden Meditech Main Business
- 5.15.3 Golden Meditech Products, Services and Solutions
- 5.15.4 Golden Meditech Revenue (US$ Million) & (2015-2020)
- 5.15.5 Golden Meditech Recent Developments
- 5.16 Guanhao Biotech
- 5.16.1 Guanhao Biotech Profile
- 5.16.2 Guanhao Biotech Main Business and Company’s Total Revenue
- 5.16.3 Guanhao Biotech Products, Services and Solutions
- 5.16.4 Guanhao Biotech Revenue (US$ Million) (2015-2020)
- 5.16.5 Guanhao Biotech Recent Development and Reaction to Covid-19
- 5.17 Beroni Group
- 5.17.1 Beroni Group Profile
- 5.17.2 Beroni Group Main Business
- 5.17.3 Beroni Group Products, Services and Solutions
- 5.17.4 Beroni Group Revenue (US$ Million) & (2015-2020)
- 5.17.5 Beroni Group Recent Developments
6 North America
- 6.1 North America Immuno-Cell Therapy Market Size by Country
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Immuno-Cell Therapy Market Size by Country
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Immuno-Cell Therapy Market Size by Region
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Immuno-Cell Therapy Market Size by Country
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Immuno-Cell Therapy Market Size by Country
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Immuno-Cell Therapy Market Dynamics
- 11.1 Industry Trends
- 11.2 Market Drivers
- 11.3 Market Challenges
- 11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Immuno-Cell Therapy. Industry analysis & Market Report on COVID-19 Impact on Global Immuno-Cell Therapy is a syndicated market report, published as COVID-19 Impact on Global Immuno-Cell Therapy Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Immuno-Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
